467 related articles for article (PubMed ID: 8970587)
1. Dysplastic nevi and other risk markers for melanoma.
Seykora J; Elder D
Semin Oncol; 1996 Dec; 23(6):682-7. PubMed ID: 8970587
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for melanoma incidence in prospective follow-up. The importance of atypical (dysplastic) nevi.
Schneider JS; Moore DH; Sagebiel RW
Arch Dermatol; 1994 Aug; 130(8):1002-7. PubMed ID: 8053695
[TBL] [Abstract][Full Text] [Related]
3. Melanoma risk in individuals with clinically atypical nevi.
Kang S; Barnhill RL; Mihm MC; Fitzpatrick TB; Sober AJ
Arch Dermatol; 1994 Aug; 130(8):999-1001. PubMed ID: 8053717
[TBL] [Abstract][Full Text] [Related]
4. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma.
Banky JP; Kelly JW; English DR; Yeatman JM; Dowling JP
Arch Dermatol; 2005 Aug; 141(8):998-1006. PubMed ID: 16103329
[TBL] [Abstract][Full Text] [Related]
5. Dysplastic nevi and malignant melanoma.
Crutcher WA; Cohen PJ
Am Fam Physician; 1990 Aug; 42(2):372-85. PubMed ID: 2200246
[TBL] [Abstract][Full Text] [Related]
6. Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. A case-control study.
Halpern AC; Guerry D; Elder DE; Clark WH; Synnestvedt M; Norman S; Ayerle R
Arch Dermatol; 1991 Jul; 127(7):995-9. PubMed ID: 2064418
[TBL] [Abstract][Full Text] [Related]
7. Monitoring of kindreds with hereditary predisposition for cutaneous melanoma and dysplastic nevus syndrome: results of a Swedish preventive program.
Hansson J; Bergenmar M; Hofer PA; Lundell G; Månsson-Brahme E; Ringborg U; Synnerstad I; Bratel AT; Wennberg AM; Rosdahl I
J Clin Oncol; 2007 Jul; 25(19):2819-24. PubMed ID: 17602087
[TBL] [Abstract][Full Text] [Related]
8. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
Landi MT; Kanetsky PA; Tsang S; Gold B; Munroe D; Rebbeck T; Swoyer J; Ter-Minassian M; Hedayati M; Grossman L; Goldstein AM; Calista D; Pfeiffer RM
J Natl Cancer Inst; 2005 Jul; 97(13):998-1007. PubMed ID: 15998953
[TBL] [Abstract][Full Text] [Related]
9. Dysplastic nevi in relation to superficial spreading melanoma.
Titus-Ernstoff L; Barnhill RL; Duray PH; Ernstoff MS; Kirkwood JM
Cancer Epidemiol Biomarkers Prev; 1993; 2(2):99-101. PubMed ID: 8467253
[TBL] [Abstract][Full Text] [Related]
10. A natural history of melanomas and dysplastic nevi: an atlas of lesions in melanoma-prone families.
Tucker MA; Fraser MC; Goldstein AM; Struewing JP; King MA; Crawford JT; Chiazze EA; Zametkin DP; Fontaine LS; Clark WH
Cancer; 2002 Jun; 94(12):3192-209. PubMed ID: 12115352
[TBL] [Abstract][Full Text] [Related]
11. Frequency of dysplastic nevi among nevomelanocytic lesions submitted for histopathologic examination. Time trends over a 37-year period.
Barnhill RL; Kiryu H; Sober AJ; Mihm MC
Arch Dermatol; 1990 Apr; 126(4):463-5. PubMed ID: 2321991
[TBL] [Abstract][Full Text] [Related]
12. The impact of total body photography on biopsy rate in patients from a pigmented lesion clinic.
Risser J; Pressley Z; Veledar E; Washington C; Chen SC
J Am Acad Dermatol; 2007 Sep; 57(3):428-34. PubMed ID: 17624623
[TBL] [Abstract][Full Text] [Related]
13. Genetic study of familial uveal melanoma: association of uveal and cutaneous melanoma with cutaneous and ocular nevi.
Smith JH; Padnick-Silver L; Newlin A; Rhodes K; Rubinstein WS
Ophthalmology; 2007 Apr; 114(4):774-9. PubMed ID: 17207529
[TBL] [Abstract][Full Text] [Related]
14. Multiple primary melanoma revisited.
Blackwood MA; Holmes R; Synnestvedt M; Young M; George C; Yang H; Elder DE; Schuchter LM; Guerry D; Ganguly A
Cancer; 2002 Apr; 94(8):2248-55. PubMed ID: 12001124
[TBL] [Abstract][Full Text] [Related]
15. [Nevus and malignant cutaneous melanoma].
Morales Suárez-Varela MM; Llopis González A; Lacasaña Navarro M; Ferrándiz Ferragud J
Rev Sanid Hig Publica (Madr); 1991; 65(3):233-8. PubMed ID: 1801183
[TBL] [Abstract][Full Text] [Related]
16. [Connection between uveal melanoma and dysplastic naevus syndrome].
Hammer H; Tóth-Molnár E; Oláh J; Dobozy A
Magy Onkol; 2005; 49(1):15-8. PubMed ID: 15902328
[TBL] [Abstract][Full Text] [Related]
17. The early and intermediate precursor lesions of tumor progression in the melanocytic system: common acquired nevi and atypical (dysplastic) nevi.
Elder DE; Clark WH; Elenitsas R; Guerry D; Halpern AC
Semin Diagn Pathol; 1993 Feb; 10(1):18-35. PubMed ID: 8506414
[TBL] [Abstract][Full Text] [Related]
18. Important risk factors in melanoma from the Dermato-Oncologic Unit of Brescia, Italy.
Manganoni AM; Zanotti F; Farisoglio C; Feroldi P; Facchetti F; Calzavara-Pinton P
Dermatol Online J; 2010 Jan; 16(1):17. PubMed ID: 20137759
[TBL] [Abstract][Full Text] [Related]
19. [Dysplastic nevus syndrome with familial melanoma (type D2)].
Casanova JM; Panadés MJ; Ramos J; Salvatella N
Med Clin (Barc); 1989 Mar; 92(10):382-4. PubMed ID: 2716387
[TBL] [Abstract][Full Text] [Related]
20. Dysplastic nevi. Their significance and management.
Elder DE
Dermatol Clin; 1988 Apr; 6(2):257-69. PubMed ID: 3288385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]